Lv5
1210 积分 2024-05-14 加入
Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory Biomarkers
20小时前
待确认
PCSK9 in Familial Hypercholesterolemia and Beyond
5天前
已完结
Comparison of the prognostic value of different arterial sites atherosclerosis risk markers for development of Macro- and microvascular complications in individuals with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort study
5天前
已完结
Changes in non-culprit coronary lesions with PCSK9 inhibitors: the randomised, placebo-controlled FITTER trial
5天前
已关闭
Early Invasive or Conservative Strategies for Older Patients With Acute Coronary Syndromes
5天前
已完结
PCSK9 Inhibitors: A Potential Priority Choice for Lipid Management in Patients with Diabetic Kidney Disease
5天前
已完结
Cholesterol Crystals as Triggers of NLRP3 Inflammasome Activation in Atherosclerosis
5天前
已完结
The effect of moderate-dose versus double-dose statins on patients with acute coronary syndrome in China: Results of the CHILLAS trial
26天前
已关闭
Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial
27天前
已完结
Planificación del tratamiento hipolipemiante en la enfermedad vascular ateroesclerótica. Consenso SEC/SEA/SEEN/SEMFYC/SEMERGEN/SEMG/SEN/SEACV/S.E.N
1个月前
已关闭
皖公网安备34019202002308
